As of 2026-07-15, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (25.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -233.4%.
The range of the Relative Valuation is (23.52) - (25.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 17.5x | 17.4x |
| Forward P/E multiples | 14.2x - 18.0x | 17.0x |
| Fair Price | (23.52) - (25.76) | (25.35) |
| Upside | -223.8% - -235.6% | -233.4% |
| Date | P/E |